Physician profile
Kyle P Schuler
NPI 1457858938
$5,507.38
in general payments reported to CMS, 2019-2025
19 companies · $4,369 in 2025
The $4,369 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $20.52 · 2024: $1,118 · 2025: $4,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,007 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,007.38 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,623.75 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $817.28 | 2024-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $666.45 | 2024-2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $617.07 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $245.39 | 2024-2025 | Dupixent |
| Insmed, INC. | $223.21 | 2024-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $217.91 | 2024-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $190.08 | 2024-2025 | Winrevair, Zerbaxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.34 | 2023-2025 | Ofev |
| Viatris Specialty LLC | $165.01 | 2025 | Yupelri |
| Amgen INC. | $117.41 | 2024-2025 | Tezspire |
| Ani Pharmaceuticals, INC. | $100.12 | 2025 | Purified Cortrophin Gel |
| Verona Pharma, INC. | $92.30 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $86.43 | 2024-2025 | Uptravi, Opsynvi, Opsumit |
| Mallinckrodt Hospital Products INC. | $76.94 | 2024-2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.80 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Liquidia Technologies, INC. | $22.60 | 2025 | Yutrepia |
| La Jolla Pharmaceutical Company | $17.29 | 2025 | Giapreza |
| Philips North America LLC | $17.00 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Schuler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.